The NF2 gene product, merlin/schwannomin, is a cytoskeleton organizer with unique growth-inhibiting activity in specific cell types. A narrow spectrum of tumors is associated with NF2 deficiency, mainly schwannomas and meningiomas, suggesting cell-specific mechanisms of growth control. We have investigated merlin function in mouse Schwann cells (SCs). We found that merlin regulates contact inhibition of proliferation by limiting the delivery of several growth factor receptors at the plasma membrane of primary SCs. Notably, upon cellto-cell contact, merlin downregulates the membrane levels of ErbB2 and ErbB3, thus inhibiting the activity of the downstream mitogenic signaling pathways protein kinase B and mitogen-activated protein kinase. Consequently, loss of merlin activity is associated with elevated levels of ErbB receptors in primary SCs. We also observed accumulation of growth factor receptors such as ErbB2 and 3, insulin-like growth factor 1 receptor and plateletderived growth factor receptor in peripheral nerves of Nf2-mutant mice and in human NF2 schwannomas, suggesting that this mechanism could play an important role in tumorigenesis.
Introduction
Merlin is the product of the NF2 tumor suppressor gene that shares strong sequence and structural homology with the ERM proteins (Ezrin, Radixin and Moesin), as well as the capacity to bind to F-actin and plasma membrane proteins (Bretscher et al., 2002) . Merlin inhibits the proliferation of many different cell types, although the proposed mechanisms vary considerably. Merlin was shown to downregulate a wide range of mitogenic signaling pathways, such as Ras, Rac or PI3K (Fraenzer et al., 2003; Kissil et al., 2003; Lim et al., 2003; Hirokawa et al., 2004; McClatchey and Giovannini, 2005; Morrison et al., 2007) . Moreover, Nf2 inactivation results in destabilization of adherens junctions (AJs) that are essential for contact inhibition of proliferation in mouse embryonic fibroblasts (MEFs) (Lallemand et al., 2003) . In addition, merlin can block ligandinduced epidermal growth factor receptor internalization and signaling in various cell types (Curto et al., 2007) . In a rat schwannoma cells, merlin also inhibits growth by promoting platelet-derived growth factor receptor (PDGFR) degradation (Fraenzer et al., 2003) . Finally, in Drosophila, D-Merlin and Expanded cooperate to stimulate endocytosis of membrane proteins, such as Notch and epidermal growth factor receptor, thereby reducing their levels at the cell surface and inhibiting downstream signaling (Maitra et al., 2006) . Despite these pieces of evidence, there is no consensus as to whether these mechanisms are central to specific NF2-related tumors. One striking feature of NF2 is the narrow tumor spectrum composed essentially of benign schwannomas and meningiomas. Therefore, we decided to study merlin function in mouse Schwann cells (SCs) that are most likely to provide pertinent information about the molecular mechanisms of NF2 tumor suppression.
Large cultures of primary SC can be derived from mice harboring a conditional Nf2 allele (Giovannini et al., 2000; Manent et al., 2003) . In these cells, Nf2 is inactivated following adenovirus-mediated Cre expression, allowing the study of the early consequences of merlin loss on SC proliferation and tumor initiation. We found that merlin controls contact-dependent inhibition of SC proliferation by inhibiting the delivery of receptors to the plasma membrane. Notably, merlin downregulates the membrane levels of ErbB2 and ErbB3, thus inhibiting downstream mitogenic signaling pathways. Moreover, we show that loss of merlin activity is associated with elevated levels of ErbB receptors in peripheral nerves of Nf2-mutant mice as well as in human NF2 schwannomas. Taken together, our data suggest that the altered delivery of ErbB receptors plays a major role in schwannoma development.
Results

Proliferative advantage of Nf2
À/À SCs We did not observe any difference in the growth rates between Nf2 þ / þ and Nf2 À/À SCs as long as they remained subconfluent (Supplementary Figure 1) . Once Nf2 þ / þ SC cultures reached confluence, we saw progressive growth arrest between days 5 and 13 of culture ( Figure 1a ). In contrast, Nf2 À/À SCs kept growing and reached saturation densities 2-3 times higher than Nf2 þ / þ SCs (Figures 1a-c). Adenovirus-mediated reexpression of merlin was sufficient to restore saturation densities similar to those observed in Nf2 þ / þ SCs, illustrating that loss of merlin was responsible for the phenotype (Figures 1b and c) .
Primary cells in culture undergo progressive and irreversible growth arrest after several passages, a process referred to as replicative senescence. Primary mouse cells can escape this fate by losing expression of tumor suppressor genes, such as p21
Cip , p53 or pRb (Bringold and Serrano, 2000; Itahana et al., 2004) . We observed that Nf2 þ / þ SCs became senescent after five to seven passages in culture when they stopped proliferating, lost their bipolar shape and became very large and flat, the typical morphological features of senescent cells (Figures 1d and e) . In contrast, Nf2 À/À SCs never stopped proliferating ( Figure 1d ) and showed none of the morphological features of senescence (Figure 1e ). Although levels of p107, p130, p53, p19
Arf and p21
Cip increased in late-passage Nf2 À/À SCs, their expression levels remained always lower than in Nf2
Kip levels were not affected by Nf2 inactivation. Beyond passage 8, Nf2
À/À SCs never became senescent and spontaneously transformed.
Transmembrane receptors accumulate at the plasma membrane of Nf2-deficient SCs Following Nf2 inactivation in SCs, we observed a clear morphological change (Figure 2a , upper panels) and profound alterations of the actin cytoskeleton ( Figure 2a , lower panels), suggesting that, as in MEFs (Lallemand et al., 2003) , Nf2 inactivation results in the loss of cell-cell contact. AJs were visualized by staining of b-catenin, a component of these structures. In contrast to Nf2
SCs, staining of b-catenin in Nf2-deficient SCs was not clearly localized in regions of cell-cell contact (Figure 2a , middle panels). These observations suggest that upon merlin loss, junctional components are expressed but not properly localized. Next, we investigated whether loss of merlin expression modified the abundance or localization of other plasma membrane proteins involved in SC proliferation, such as growth factor and adhesion receptors. We found that the amounts of several growth factor receptors (ErbB2, ErbB3, insulin-like growth factor 1 receptor (IGF1R), PDGFR-b) and adhesion molecules (N-and E-cadherin) were elevated in total membrane extracts from confluent Nf2 À/À SCs compared with Nf2
SCs, whereas b-catenin levels were not (Figure 2b ). These observations were confirmed by surface protein biotinylation (Figure 2d ). In contrast, receptor levels were nearly identical in subconfluent Nf2 þ / þ SCs and Nf2 Figure 2) . Quantification of the signals showed that the higher levels of receptors were associated with an increase of phosphorylated receptors. These molecular phenotypes were strictly regulated by merlin because its reintroduction into Nf2 À/À SCs markedly reduced the levels of ErbB2, ErbB3, IGF1R, PDGFR-b and E-and N-cadherin at the plasma membrane (Figures 2c and d) . Quantification of specific markers EEA1, Lamp1, p115 or Rab11 in membrane extracts by western blot (Figure 2e ) and by immunofluorescence staining (Supplementary Figure 3) suggested that the accumulation of membrane proteins in Nf2 À/À SCs was not the result of an expansion of intracellular compartments, such as the Golgi apparatus or the endocytic vesicles. In addition, saturation of the plasma membrane with the lipophilic fluorescent dye FM1-43X demonstrated that this compartment was not enlarged in Nf2 À/À SCs (Figure 2f ). Finally, quantitative reverse transcription-PCR (RT-PCR) analysis showed no increase of ErbB2, ErbB3 and IGF1R mRNA expression levels in Nf2 À/À SCs and a slight increase of Pdgfrb (1.3-fold). Only N-cadherin mRNA levels were increased following loss of merlin expression (Figure 2g ). In conclusion, Nf2 inactivation in SCs leads to the accumulation of growth factor receptors at the plasma membrane, which is not due to increased protein synthesis.
Merlin regulates the delivery of growth factor receptors to the plasma membrane in SCs Several reports have proposed a role for merlin in protein transport (Maitra et al., 2006; Curto et al., 2007) and the involvement of the ERM proteins in vesicular trafficking is well established (Pujuguet et al., 2003; Tamma et al., 2005; Stanasila et al., 2006) . We compared growth factor internalization in Nf2 þ / þ and Nf2 À/À SC cultures using a surface protein biotin pulsechase approach and found no differences (data not shown). As the phenotype might be too subtle to be detected using this method, we decided to overexpress merlin in Nf2 À/À SCs to accentuate a putative trafficking defect. We observed no difference in the rate of internalization of the receptors 20 min after the biotin pulse (or at later times) when comparing Nf2 À/À SCs with Nf2 À/À SCs overexpressing merlin (Nf2 À/À;adNF2 ) ( Figure 3a) . Secondly, we investigated the rate of degradation of surface receptors in Nf2 À/À and Nf2
À/À;adNF2
SCs, and again found no difference ( Figure 3b ). Next, we explored the role of merlin in vesicular transport from the Golgi apparatus to the plasma membrane (Figure 3c ). We took advantage of the temperature-sensitive mutant of the viral VSVprotein (ts045VSV) fused to the green fluorescent protein (GFP) that has been widely used for these types of studies (Hirschberg et al., 1998; Siskova et al., 2006) . At 40 1C, the ts045VSV-GFP protein is misfolded and retained in the endoplasmic reticulum. At 32 1C, the fusion protein folds properly, synchronously moves to the Golgi apparatus and is transported to the plasma membrane where its accumulation can be followed using surface protein biotinylation. In myoblasts, N-cadherin and ts045VSV-GFP colocalized in secretory vesicles (Mary et al., 2002) . Similarly, ErbB2, ErbB3, IGF1Rb and PDGFR-b colocalized with ts045VSV-GFP in Figure 3c demonstrated that ts045VSV-GFP protein accumulation at the plasma membrane was inhibited by merlin overexpression. The presence of a cleavage product of ts045VSV-GFP in total extracts from Nf2 À/À;adNF2 (arrow in Figure 3c , right panel) suggested that some of the protein that is not delivered to the plasma membrane was targeted for degradation. In conclusion, merlin controls the amount of adhesion and growth factor receptors at the cell surface of SCs by inhibiting their delivery to the plasma membrane.
Accumulation of the ErbB receptors at the plasma membrane confers a growth advantage to SCs Our observations suggested that increased levels of growth factor receptors at the plasma membrane of Nf2 À/À SCs stimulate downstream mitogenic pathways and trigger proliferative advantage. Heregulin-b1, the ligand for ERbB3, is the only growth factor present in the define media that we used for primary SC cultures. When heregulin-b1 concentration was lowered, ErbB receptor activity decreased and contact inhibition was restored in Nf2 À/À SC ( Figure 4a ). A sharp decrease of the replication potential ( Figure 4b ) and the induction of a senescent morphology similar to that of Nf2 þ / þ SC at the same passage (compare phase contrast images in Figure 4b and Figure 1e ) were also observed. In contrast, reducing the concentration of insulin had no effect on the proliferation rate (data not shown) or the replicative potential of Nf2 À/À SC ( Figure 4b ). These data strongly suggested that the increased saturation density of Nf2 À/À SCs was the consequence of the accumulation of ErbB receptors. Western blot analysis showed that mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) pathways were activated in confluent Nf2 À/À SC ( Figure 4c ). Reducing heregulin-b1 concentration in Nf2 À/À SC cultures resulted in lower levels of phosphorylated Akt and MAPK. Conversely, overexpressing human ErbB2 (HER2) in Nf2 þ / þ SCs stimulated MAPK and Akt phosphorylation and activity ( Figure 4d ). Finally, specific inhibition of ErbB2, MEK/MAPK or PI3K/Akt leads to a drastic reduction of Nf2 À/À SC proliferation (Figure 4e ), showing that these pathways are essential for SC proliferation in culture. In conclusion, we found that the cell surface accumulation of ErbB receptors at confluence in Nf2 À/À SCs stimulates mitogenic MAPK and PI3K/Akt pathways leading to persistent proliferation and increased saturation densities.
Increased levels of growth factor receptors in Nf2-mutant mouse peripheral nerves and in human schwannomas To test whether the accumulation of receptors that we observed in Nf2 À/À SCs was relevant for tumor formation, we analysed the expression of growth factor receptors in mouse peripheral nerves. We found that ErbB3, IGF1R and PDGFR-b expression levels were elevated in Nf2-mutant peripheral nerves as compared with wild-type nerves (Figures 5a and b) . N-cadherin levels were also increased (Figure 5a) . Strikingly, the overall pattern of membrane protein accumulation in Nf2-mutant peripheral nerves, before the development of tumors, matched the pattern we described in Nf2
SCs. This observation showed that the molecular consequences of loss of merlin expression in SCs are context independent. Next, we compared the expression levels of several plasma membrane proteins in a series of eight human schwannomas that did not express merlin (five from sporadic tumors and three from NF2 patients) and in three normal human nerves. Western blot analysis (Figure 5c ) showed that, as for mouse Nf2-mutant nerves, levels of HER2, HER3, IGF1R, PDGFR-b and N-cadherins were clearly elevated in schwannomas. Accordingly, immunohistochemical analysis of HER2, HER3, PDGFR-b and N-cadherins showed strong immunostaining on tumor tissue and a weaker staining pattern in control nerves (Figure 5d ). Differences in HER2, HER3 and N-cadherin expression in a series of 30 human schwannomas and 8 normal nerves were quantified by scoring staining intensities. Statistically significant differences between normal nerves and schwannomas were observed for HER2, HER3 and N-cadherin (Figure 5e ). mRNA expression levels of HER2, HER3, IGF1R and PDGFR-b genes were not significantly increased in human schwannomas compared with normal nerves (Figure 5f ). In contrast, N-cadherin mRNA expression was upregulated in human schwannomas as it was in mouse Nf2 À/À SC cultures. These observations strengthen our hypothesis that deregulated transport is responsible for the accumulation of growth factor receptors in human schwannomas.
In conclusion, loss of merlin expression results in the accumulation of growth factor receptors at the plasma membrane of SCs. As it is a major mechanism of the proliferative advantage of Nf2 À/À SCs in vitro, it may represent an important step in the initiation of schwannoma development in mouse NF2 models and in NF2 patients.
Discussion
Although regulation of merlin activity is well understood, the mechanisms of its tumor suppressive function remain elusive (McClatchey and Giovannini, 2005) . AJs are central to the process of contact inhibition of cell growth. Upon cadherin engagement, the activity of receptors tyrosine kinases and downstream mitogenic signaling pathways is progressively inhibited (Qian et al., 2004; Perrais et al., 2007) . The mislocalization of some of the AJ components in confluent Nf2 À/À SCs indicates that AJs might be dysfunctional in SCs. Nevertheless, the fact that lowering the concentration of heregulin-b1 restored contact inhibition in Nf2 À/À SCs suggested that AJs could still contribute to growth inhibition in these cells. Our data support the hypothesis that in Nf2 À/À SCs, AJs cannot efficiently inhibit the elevated mitogenic signaling arising from increased ErbB levels and that the net result of the antagonistic relationship between receptors tyrosine kinases and AJs is shifted toward promitogenic signaling. We found that, in SCs, merlin regulates the expression of various receptors at the cell surface. These observations agree with the function proposed for merlin in Drosophila where the combined loss of D-Merlin and the tumor suppressor Expanded in the eye results in the accumulation of several membrane proteins (Maitra et al., 2006) . Although merlin and Expanded modulate growth factor receptor internalization in Drosophila, our data indicate that, in SCs, merlin inhibits the delivery of proteins to the plasma membrane. This difference could be accounted for by the concomitant Expanded inactivation in Drosophila, as single D-Merlin or Expanded inactivation did not affect internalization. Tissue-specific factors could also explain the differences across species, as in MEFs, osteoblasts and liver-derived cells, merlin inhibits epidermal growth factor receptor internalization upon cell-cell contact preventing the activation of downstream signaling pathways (Curto et al., 2007) .
Following release from the Golgi apparatus, the ts045VSV-GFP construct is partially degraded in merlin-expressing SC, suggesting that a fraction of the protein pool was directly targeted for degradation. Interestingly, in a schwannoma cell line, merlin regulates membrane levels of PDGFR-b by inducing its degradation (Fraenzer et al., 2003) , revealing an additional degree of complexity in merlin regulation of growth factor steady state levels. ERM proteins also are implicated in vesicular trafficking (Pujuguet et al., 2003; Deretic et al., 2004; Stanasila et al., 2006) . Thus, merlin and ERM proteins regulate protein transport to and from the plasma membrane. The fact that ERM proteins do not compensate for merlin loss suggests that they control independent pathways. How merlin modulates the delivery of proteins to the plasma membrane remains unknown. Interestingly, membrane fusion of secretory vesicles requires localized actin remodeling. In some cases actin acts as a physical barrier preventing the access to the plasma membrane (Muallem et al., 1995; Miyake et al., 2001) . The severe actin disorganization induced by merlin loss (Figure 2a ) might facilitate vesicle fusion with the plasma membrane and protein delivery. Alternatively, merlin could spatially restrict growth factor receptors and adhesion molecules accumulation within the plasma membrane. In SCs, it has been reported that merlin interacts with ErbB2 hence controlling its subcellular localization (Fernandez-Valle et al., 2002) . Therefore, loss of merlin expression could allow for a broader distribution of membrane-associated proteins. From our study and others, it appears that merlin regulates growth factor receptor presence at the plasma membrane of confluent cells in several ways. The different mechanisms proposed may reflect the predominance of a particular merlin function in a specific organism or cell type, and underscore the relevance of using SC in our study for the understanding of human schwannomagenesis. We have also presented strong evidence that ErbB-mediated activation of downstream mitogenic signaling pathways is important for schwannoma development. In vitro, expression of a constitutively activated form of ErbB2 in rat SC promotes transformation (Sherman et al., 1999) . In vivo, chemically induced activating mutations of ErbB2 trigger malignant schwannoma development in rodents (Nikitin et al., 1991; Buzard et al., 1999) . Thus, it appears that in SC, strong activation of ErbB signaling due to an oncogenic mutation of ErbB2 promotes malignant tumorigenesis, whereas a milder activation following the accumulation of wild-type ErbB receptors results in a benign tumorigenic process. Surprisingly, no oncogenic ErbB2 mutations have been ever found in human schwannomas.
Our study shows that expression levels of growth factor receptors known to be involved in SC proliferation and survival are increased in peripheral nerves isolated from two different types of Nf2-mutant mice. Moreover, protein expression analysis performed on schwannoma biopsies convincingly showed increased levels of the corresponding ortholog proteins, notably HER2 and HER3. These results support the hypothesis that schwannoma development in NF2 patients is linked to the accumulation of ErbBs receptors. This conclusion is reinforced by several studies that show upregulation and activation of ErbBs and downstream signaling pathways, such as PI3K/Akt and MAPK, in schwannomas (Hansen and Linthicum, 2004; Stonecypher et al., 2006) . Although ErbB signaling is most likely to play a key role in schwannoma development, IGF1R and PDGFR-b are also involved in SC survival and þ / þ and Nf2 À/À subconfluent primary SCs. Scale bars ¼ 10 mm. Middle two panels: b-catenin staining of fixed confluent primary Nf2 þ / þ and Nf2 À/À SCs (green) and 4,6-diamidino-2-phenylindole (DAPI) (blue). Scale bars ¼ 5 mm. Lower two panels: rhodamine-phalloidin staining of actin in the same field (red) and DAPI (blue). Scale bars ¼ 5 mm. (b) Western blot analysis of total and phosphorylated growth factor receptors levels (insulin-like growth factor 1 receptor (IGF1R), ErbB2 and 3 and platelet-derived growth factor receptor (PDGFR)-b) and adhesion molecules (N-cadherin, E-cadherin and b-catenin) in membrane extracts from early confluent Nf2 þ / þ and Nf2 À/À primary SCs at passage 3. Actin was used as a loading control and lack of merlin expression in Nf2 À/À SC was confirmed. Quantification of the signals is presented and was normalized to the wild-type SC signal after correction from the actin control. À/À;adNf2 SCs and the presence of a cleavage product (arrow). Bottom: graphic representation of the kinetic of ts045VSV-GFP transport to the plasma membrane. Western blot was scanned and quantified using imageQ software. The relative abundance of ts045VSV-GFP has been corrected from the lower total amount of ts045VSV-GFP present in Nf2 À/À;adNf2 SC extracts. (d) ts045VSV-GFP and ErbB2 colocalize in vesicles following their release from the Golgi (scale bars ¼ 2 mm). Primary SCs expressing ts045VSV-GFP were treated overnight with 3 mg/ml of brefeldin A, a drug that blocks the release of newly synthesized proteins from the Golgi. Following the release from the block, progression of ts045VSV-GFP and ErbB2 in transport vesicles was followed by immunofluorescence. Colocalization with several other receptors is presented in Supplementary Figure 4. proliferation (Hardy et al., 1992; Syroid et al., 1999; Cheng et al., 2000; Lobsiger et al., 2000) . We showed that these receptors are also upregulated in Nf2 À/À SCs, in mouse Nf2-mutant nerves and in human schwannomas. Therefore, the precise role of IGF1R and PDGFR-b in schwannoma development needs further clarification. Jozwiak, 2006) . Hence, the role of these proteins in vesicular trafficking could be key to their tumor suppressing activity. As the study of dysregulated protein transport is becoming a major theme in cancer research (Bache et al., 2004; Polo et al., 2004) , elucidating how the tumor suppressor merlin controls protein transport constitutes an essential contribution in this emerging field.
Materials and methods
Mouse models
The two mouse models used in our study were described previously. Briefly, in the first model, the floxed Nf2 gene was conditionally inactivated in SCs in vivo by tissue-specific expression of the Cre recombinase under the control of the P0 promoter (Giovannini et al., 2000) . In the second model, SCspecific P0 promoter was used to drive the expression of a dominant negative mutant merlin (Sch-D39-121) (Giovannini et al., 1999) . This model was used for experiments involving extracts from sciatic nerves.
Cell cultures
All primary SC cultures were derived from the Nf2 flox/flox mouse model. Primary mouse SC cultures were produced from adult Nf2 flox/flox mouse sciatic nerves and P75-mediated cell sorting of SCs (Manent et al., 2003) was used for SC purification. SCs were routinely cultured in N2 media (DMEM-F12 with 2 mM forskolin, 10 ng/ml heregulin, 50 mg/ml gentamicin, 2.5 mg/ml fungizone and N2 supplement (Gibco, Invitrogen, Cergy Pontoise, France)). Cre-adenovirus-mediated Nf2 (Ad5CMV-Cre, University of Iowa Gene Transfer Vector Core, Iowa City, IA, USA) was assessed by western blot. For each experiment, control SCs were infected with either an empty adenovirus or an adenovirus expressing b-galactosidase. For growth curves, SCs were seeded at 7.5 Â 10 4 cells/cm 2 , and counted daily. For senescence studies, SCs were seeded at 5 Â 10 4 cells/cm 2 at each passage and counted after 7 days. The number of cell doublings (N) was calculated as follows:
. N i is the number of plated SCs and N f is the number of SCs counted after 1 week. Experiments were repeated at least three times.
Adenovirus production and SC infection
Merlin isoform 1 and ts045VSV-GFP adenoviruses were prepared using the Adeasy system (Stratagene, Agilent, Massy, France). Infection efficiencies close to 100% were assessed by immunofluorescence.
Protein analysis and antibodies
Total cell and membrane extract preparation were described previously (Lallemand et al., 2003) . For mouse peripheral nerve extracts, sciatic nerves from 2-to 6.5-month-old mice were dissected and solubilized in 9 M urea by trituration on ice with an Ultrathurrax (IKA Labortechnik, Staufen, Germany) and sonicated. Debris were removed by centrifugation at 20 000 g (10 min at 4 1C). All mice used for analysis were FVB/N mixed strain with littermates serving as controls. Animal care and experimentation reported herein were conducted in compliance with the guidelines and with the approval of Institutional Animal Care and Use Committee of the French Department of Agriculture. The study involving human tumor samples was conducted after approval from the Comite´Consultatif des Personnes Participant a`une Recherche Biomedicale. Tumor and nerve samples were obtained from patients who provided informed consent. Extracts from human nerves and schwannomas were prepared in 9 M urea, as above. Protein concentration was measured by Bradford assay (Bio-Rad, Marnes la Coquette, France). For western blotting, proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose. Membranes were incubated with primary antibodies overnight at 4 1C in phosphate-buffered saline (PBS) þ 0.1% Tween and 5% nonfat dry milk, or PBS þ 0.1% Tween 20 and 2% bovine serum albumin for phospho-specific antibodies. Immunofluorescence Schwann cells were fixed on glass coverslips for 20 min in 4% formaldehyde, permeabilized for 10 min in PBS with 0.2% Triton X-100 and incubated overnight at 4 1C with the primary antibody in PBS plus 0.1%Tween and 10% fetal calf serum. Samples were incubated for 2 h at room temperature with the secondary antibody (Amersham Bioscience), and mounted on a glass slide using Citifluor mounting media (Citifluor Ltd, Biovalley, Marne la Valle´e, France).
Schwann cell membrane quantification A total of 5 Â 10 6 Nf2 À/À and Nf2 þ / þ SCs were trypsinized and rinsed in PBS. After centrifugation at 500 g for 5 min, cells were resuspended in 3 ml of ice-cold HBSS containing 5 mg/ml of FM1-43 FX lipophylic styryl dye (Molecular Probes, Invitrogen, Cergy Pontoise, France) for 10 min on ice. Formaldehyde (4%) was added for 20 min on ice. Following two rinses in HBSS, fluorescence of the incorporated dye was quantified by fluorescence-activated cell sorting.
Cell surface proteins biotinylation
For all the experiments involving cell surface protein biotinylation, SCs were plated at 5 Â 10 4 cells/cm 2 and grown for 5-7 days until they reached early confluence. Biotinylation of surface proteins was performed for 30 min at 4 1C using the Pinpoint Cell Surface Protein Isolation Kit (Pierce) and following instructions from the manufacturer. For experiments involving merlin re-expression, Nf2 À/À SCs were infected with merlin (isoform I) expressing adenovirus 1 day after plating and processed as above.
Surface receptors clearance experiment
Following surface protein biotinylation pulse, confluent SCs were placed back in culture media at 37 1C for the indicated time points. Then, SCs were collected and biotinylated proteins were extracted from equal amounts of extracts following the instructions from the manufacturer.
Receptor internalization experiment
Nf2
À/À cells were seeded at 5 Â 10 4 cells/cm 2 . After 1 day, onehalf of the plates were infected with merlin-expressing adenovirus to generate Nf2 À/À;adNF2 SCs. After 5-7 days, when cultures reached early confluence, Nf2 À/À and Nf2 À/À;adNF2 SCs were biotinylated for 30 min at 4 1C and placed back in culture media at 37 1C for the indicated time. Then, biotin groups still exposed at the cell surface were stripped (two incubations at 4 1C in 75mM NaCl, 50 mM NaOH, 50 mM glutathione). Internalized proteins protected from stripping and still biotinylated were purified from equal amounts of cell extracts and analysed by western blot.
ts045VSV-GFP cytoplasmic membrane delivery quantification Nf2 À/À SCs were infected with adenovirus expressing the ts045VSV-GFP. After 1 day, half of the culture was infected with adenovirus expressing merlin isoform 1 and the other half with a control adenovirus. After 2 days, cells were switched to 40 1C for 36 h. Then, surface proteins were biotinylated 0, 1, 2, 4 and 8 h following switch to 32 1C. Biotinylated proteins were purified from equal amounts of cell extracts for each time point, and ts045VSV-GFP expression at the surface of the cell was quantified by western blot (anti-GFP, Santa Cruz).
Immunohistochemistry
Sections of paraffin-embedded tissue (3 mm) were stained (streptavidin-peroxidase protocol, immunostainer BenchMark Ventana, Illkirch, France) with antibodies to: ErbB2 (Ab-17, LabVision, Interchim, Montluc¸on, France), phospho-ErbB2 (Ab-18, LabVision), S100 (PN IM1926, Immunotech, Marseille, France), neurofilament (clone 2F11, Dako, Trappes, France), ), ErbB3 (SGP1, LabVision) and N-cadherin (H63, Santa Cruz). For quantification, 2-4 sections of each tumor or nerve were evaluated independently by two investigators (AC and DL) and the percentage of labeled cells was estimated (P). A score (I) was attributed in function of the staining intensity (0 ¼ no staining, 1 ¼ weak staining, 2 ¼ moderate staining and 3 ¼ strong staining). A final score S ¼ P Â I was calculated for each section. Statistical analysis (mean, standard error of the mean (s.e.m.) and nonparametric paired t-test) was performed using Prism software.
RNA extraction and quality control Total RNA was extracted from confluent primary SC cultures at passage 3 using the RNeasy protocol (Qiagen, Courtaboeuf, France) with on-column Dnase I digestion (Qiagen). For schwannoma analysis, 100-200 mg of tissue was used for RNA extraction.
Total RNA from human nerves and tumors was extracted using a modified RNeasy protocol consisting of lysis in TRIzol (Invitrogen, Cergy Pontoise, France) followed by RNeasy Cleanup protocol (Qiagen). Quality of RNAs was assessed by Bioanalyser 2100 (Agilent, Massy, France). All RNAs used for further experimentation displayed a 28s/18s ratio between 1.6 and 2.1.
Quantitative RT-PCR A total of 3 mg of total RNA was reverse-transcribed in a final volume of 100 ml using the High Capacity cDNA Archive Kit with random hexamers (Applied Biosystems, Courtaboeuf, France). TaqMan gene expression assays containing genespecific primers and probe sets (Applied Biosystems) were used for the detection of mouse and human genes. RT-PCR and the quantification of RT-PCR products were performed and analysed with ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The quality of cDNAs was assessed using a ribosomal R18S quantification by RT-PCR. The relative amount of measured mRNA in samples was determined using the 2 ÀDDCT method (CT ¼ cycle threshold) where DDCT ¼ (CT target ÀCT R18s ) sample À(CT target ÀCT R18s ) calibrator . Final results are expressed as the ratio 2 ÀDDCT (Nf2 
Statistical analysis
Statistical analysis was performed using Prism 4 software. Results are reported as mean±standard deviation (s.d.). Data were analysed by unpaired t-test and differences were considered significant when Po0.05 (***Po0.001, **0.001oPo0.01, *0.01oPo0.05).
